Pascal and Francis Bibliographic Databases


Search results

Your search

au.\*:("PUNT, Cornelis J. A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 66

  • Page / 3

Selection :

  • and

Monoclonal Antibodies in the Treatment of Metastatic Colorectal Cancer: A ReviewTOL, Jolien; PUNT, Cornelis J. A.Clinical therapeutics. 2010, Vol 32, Num 3, pp 437-453, issn 0149-2918, 17 p.Article

Reversible Posterior Leukoencephalopathy Syndrome Caused by Bevacizumab : Report of a CaseKOOPMAN, Miriam; MULLER, Erik W; PUNT, Cornelis J. A et al.Diseases of the colon & rectum. 2008, Vol 51, Num 9, pp 1425-1426, issn 0012-3706, 2 p.Article

Systemic treatment of advanced colorectal carcinoma : The systemic treatment of gastro-intestinal cancersVAN LAARHOVEN, Hanneke W. M; PUNT, Cornelis J. A.European journal of gastroenterology & hepatology. 2004, Vol 16, Num 3, pp 283-289, issn 0954-691X, 7 p.Article

Trimetrexate as a biochemical modulator of 5-fluorouracil and leucovorin in colorectal cancerPUNT, Cornelis J. A.Seminars in oncology. 2000, Vol 27, Num 5, pp 88-90, issn 0093-7754, SUP10Conference Paper

Monitoring fluoropyrimidine metabolism in solid tumors with in vivo 19F magnetic resonance spectroscopyVAN LAARHOVEN, Hanneke W. M; PUNT, Cornelis J. A; KAMM, Yvonne J. L et al.Critical reviews in oncology/hematology. 2005, Vol 56, Num 3, pp 321-343, issn 1040-8428, 23 p.Article

A study to evaluate the pharmacokinetics of oral 5-fluorouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005)O'DONNELL, Anne; PUNT, Cornelis J. A; JUDSON, Ian et al.Cancer chemotherapy and pharmacology. 2003, Vol 51, Num 1, pp 58-66, issn 0344-5704, 9 p.Article

Effects of nicotinamide and carbogen in different murine colon carcinomas: Immunohistochemical analysis of vascular architecture and microenvironmental parametersVAN LAARHOVEN, Hanneke W. M; BUSSINK, Johan; LOK, Jasper et al.International journal of radiation oncology, biology, physics. 2004, Vol 60, Num 1, pp 310-321, issn 0360-3016, 12 p.Article

In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 tesla field strengthVAN LAARHOVEN, Hanneke W. M; KLOMP, Dennis W. J; KAMM, Yvonne J. L et al.Cancer research (Baltimore). 2003, Vol 63, Num 22, pp 7609-7612, issn 0008-5472, 4 p.Article

Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice EvidenceVAN GILS, Chantal W. M; DE GROOT, Saskia; REDEKOP, William K et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 8, pp 703-718, issn 1170-7690, 16 p.Article

Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancerMEKENKAMP, Leonie J. M; HAAN, Josien C; KOOPMAN, Miriam et al.Gut. 2013, Vol 62, Num 1, pp 94-101, issn 0017-5749, 8 p.Article

PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma CancerDULOS, John; CARVEN, Gregory J; JACOBS, Joannes F. M et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 2, pp 169-178, issn 1524-9557, 10 p.Article

Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting AgentsDE VRIES, I. Jolanda M; CASTELLI, Chiara; COULIE, Pierre G et al.Clinical cancer research (Print). 2011, Vol 17, Num 4, pp 841-848, issn 1078-0432, 8 p.Article

Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide usedLEWSTERHUIS, W. Joost; SCHREIBELT, Gerty; DE VRIES, I. Jolanda M et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 2, pp 249-260, issn 0340-7004, 12 p.Article

Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximabTOL, Jolien; DIJKSTRA, Jeroen R; KLOMP, Marjolein et al.European journal of cancer (1990). 2010, Vol 46, Num 11, pp 1997-2009, issn 0959-8049, 13 p.Article

5-FU-induced peripheral neuropathy: a rare complication of a well-known drugVAN LAARHOVEN, Hanneke W. M; VERSTAPPEN, Carla C. P; BEEX, Louk V. A. M et al.Anticancer research. 2003, Vol 23, Num 1B, pp 647-648, issn 0250-7005, 2 p.Article

Tumour response prediction by diffusion-weighted MR imaging: Ready for clinical use?HEIJMEN, Linda; VERSTAPPEN, Maartje C. H. M; TER VOERT, Edwin E. G. W et al.Critical reviews in oncology/hematology. 2012, Vol 83, Num 2, pp 194-207, issn 1040-8428, 14 p.Article

Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell―Based Vaccination in Metastatic MelanomaAARNTZEN, Erik H. J. G; BOL, Kalijn; SCHREIBELT, Gerty et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 23, pp 6102-6110, issn 0008-5472, 9 p.Article

Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma PatientsJACOB, Joannes F. M; PUNT, Cornelis J. A; ADEMA, Gosse J et al.Clinical cancer research (Print). 2010, Vol 16, Num 20, pp 5067-5078, issn 1078-0432, 12 p.Article

Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumoursVAN CRUIJSEN, Hester; VOEST, Emile E; VAN HERPEN, Carla M. L et al.European journal of cancer (1990). 2010, Vol 46, Num 5, pp 901-911, issn 0959-8049, 11 p.Article

Autoimmune Antibodies and Recurrence-Free Interval in Melanoma Patients Treated With Adjuvant InterferonBOUWHUIS, Marna G; SUCIU, Stefan; HERNBERG, Micaela et al.Journal of the National Cancer Institute. 2009, Vol 101, Num 12, pp 869-877, issn 0027-8874, 9 p.Article

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal CancerTOL, Jolien; KOOPMAN, Miriam; RICHEL, Dirk J et al.The New England journal of medicine. 2009, Vol 360, Num 6, pp 563-572, issn 0028-4793, 10 p.Article

Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patientsKWEEKEL, Dina M; GELDERBLOM, Hans; ANTONINI, Ninja F et al.European journal of cancer (1990). 2009, Vol 45, Num 4, pp 572-578, issn 0959-8049, 7 p.Article

Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation stateDE VRIES, I. Jolanda M; KROOSHOOP, Daniëlle J. E. B; ADEMA, Gosse J et al.Cancer research (Baltimore). 2003, Vol 63, Num 1, pp 12-17, issn 0008-5472, 6 p.Article

A phase I study of the natural killer T-cell ligand α-galactosylceramide (KRN7000) in Patients with solid tumorsGIACCONE, Giuseppe; PUNT, Cornelis J. A; ROELVINK, Marja et al.Clinical cancer research. 2002, Vol 8, Num 12, pp 3702-3709, issn 1078-0432, 8 p.Article

Route of Administration Modulates the Induction of Dendritic Cell Vaccine―Induced Antigen-Specific T Cells in Advanced Melanoma PatientsJOOST LESTERHUIS, W; DE VRIES, I. Jolanda M; VAN ROSSUM, Michelle M et al.Clinical cancer research (Print). 2011, Vol 17, Num 17, pp 5725-5735, issn 1078-0432, 11 p.Article

  • Page / 3